Enveda Biosciences Valuation, Funding & Investors

Immunai is a biotechnology company with locations in New York City, San Francisco, and Tel Aviv, mapping the immune system using single-cell genomics and machine learning. The firm profiles hundreds of immune cell types from blood samples via its proprietary database, aiding biomarker discovery for therapeutics in autoimmune diseases and cancer.

Mammoth Biosciences is a biotechnology company, co-founded by CRISPR pioneer Jennifer Doudna, that develops CRISPR-based tools for diagnostics and gene-editing therapeutics. Its platform is built around compact Cas proteins such as Cas14 and Casφ, which the company applies to in vivo gene editing for genetic and infectious diseases as well as decentralized disease detection. Mammoth has partnered with organizations including Regeneron, GSK, and the NIH, and has received government funding to develop COVID-19 testing technology.

MegaRobo is a Beijing-based robotics company, founded in 2016, that builds automation systems combining AI software, analytical instruments, laboratory hardware, and consumables for life-sciences research. Its technology targets applications such as new-drug R&D, genetic engineering, and clinical diagnostics, addressing talent shortages in laboratory work through automated testing and analysis. The company has grown to nearly 1,000 employees across offices in China, the UK, and the US, and has partnered with organizations including WuXi AppTec and Bosch.

Visby Medical is a diagnostics firm headquartered in Santa Barbara, California, specializing in rapid polymerase chain reaction tests for infectious diseases. Its instrument-free, single-use devices deliver PCR results in under 30 minutes. The company markets FDA-cleared tests for chlamydia, gonorrhea, and trichomoniasis in point-of-care and at-home formats, alongside multiplex assays for COVID-19, influenza A, and influenza B in clinical settings. Visby Medical's platform supports decentralized testing to accelerate disease detection.

Element Biosciences is a San Diego-based life sciences company building next-generation DNA sequencing instruments. The AVITI platform delivers high-accuracy reads using avidity sequencing chemistry, reducing costs through improved signal-to-noise ratios in surface chemistry and biochemistry. Launched in 2022, it supports workflows from short-read to long-read applications for genomics research. Element Biosciences serves academic labs, biopharma, and clinical sequencing markets worldwide.

Formation Bio is a South San Francisco-based biotechnology firm accelerating drug development through optimized clinical trials. It partners with pharma companies like Eli Lilly to redesign trial operations, leveraging technology for faster patient recruitment and data management in oncology and rare diseases.

MedGenome is a Bangalore-based genomics company offering next-generation sequencing diagnostics and research services for cancer, metabolic, cardiac, and rare diseases. The firm operates CLIA-certified labs in the United States and India, processing samples for over 500 hospitals and research institutions. Its platform integrates bioinformatics with population-scale data from South Asian genomes, supporting drug discovery partnerships with AstraZeneca and Bristol Myers Squibb in precision medicine initiatives.

Edgehax is a developer of AI hardware acceleration platforms designed for edge computing applications. The platform optimizes machine learning workloads on specialized hardware, targeting sectors requiring low-latency inference such as autonomous systems and real-time analytics.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.

Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.

Freenome is a South San Francisco-headquartered private biotechnology company specializing in early cancer detection via blood tests. It pioneers non-invasive screening using machine learning to analyze multiomics data for proactive management of cancers and other diseases. The approach aims to make advanced diagnostics accessible through innovative blood-based solutions.

Everly Health, formerly Everlywell, is an Austin, Texas-based digital health company founded in 2015 by Julia Cheek. It provides at-home health testing kits for conditions including thyroid issues, allergies, and food sensitivities, alongside a digital health platform and virtual care offerings, and added FDA-authorized at-home COVID-19 collection kits in 2020. The company has expanded into enterprise partnerships with employers and health plans alongside its consumer testing business.

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.